Epidermal growth factor receptor biology in head and neck cancer
- PMID: 16763281
- DOI: 10.1200/JCO.2005.04.8306
Epidermal growth factor receptor biology in head and neck cancer
Abstract
Epidermal growth factor receptor (EGFR) is overexpressed in several epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC), which exhibits EGFR overexpression in up to 90% of tumors. EGFR ligands such as transforming growth factor alpha are also overexpressed in HNSCC. EGFR plays a critical role in HNSCC growth, invasion, metastasis and angiogenesis. However, EGFR inhibitors as monotherapy have yielded only modest clinical outcomes. Potential mechanisms for lack of response to EGFR inhibition in HNSCC include constitutive activation of signaling pathways independent of EGFR, as well as genetic aberrations causing dysregulation of the cell cycle. EGFR-directed therapy may be optimized by identifying and selecting those HNSCC patients most likely to benefit from EGFR inhibition. Resistance to EGFR inhibition may be circumvented by combination therapy employing EGFR inhibitors together with other treatment modalities.
Similar articles
-
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):771-8. doi: 10.1001/archotol.132.7.771. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16847188
-
Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.Cancer Res. 2006 Dec 15;66(24):11831-9. doi: 10.1158/0008-5472.CAN-06-2876. Cancer Res. 2006. PMID: 17178880
-
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.J Cell Physiol. 2005 Nov;205(2):218-27. doi: 10.1002/jcp.20383. J Cell Physiol. 2005. PMID: 15887238
-
Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.Expert Rev Anticancer Ther. 2006 Sep;6(9):1179-93. doi: 10.1586/14737140.6.9.1179. Expert Rev Anticancer Ther. 2006. PMID: 17020453 Review.
-
Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.J Clin Oncol. 2006 Jun 10;24(17):2659-65. doi: 10.1200/JCO.2005.05.4577. J Clin Oncol. 2006. PMID: 16763280 Review.
Cited by
-
Peptide directed phthalocyanine-gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancers.RSC Med Chem. 2020 Nov 19;12(2):288-292. doi: 10.1039/d0md00284d. RSC Med Chem. 2020. PMID: 34041483 Free PMC article.
-
Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.Cancer Sci. 2012 Aug;103(8):1586-94. doi: 10.1111/j.1349-7006.2012.02332.x. Epub 2012 Jul 5. Cancer Sci. 2012. PMID: 22587416 Free PMC article. Clinical Trial.
-
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy.Cancers (Basel). 2021 May 21;13(11):2535. doi: 10.3390/cancers13112535. Cancers (Basel). 2021. PMID: 34064074 Free PMC article. Review.
-
EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations.Ann Transl Med. 2020 Jul;8(13):813. doi: 10.21037/atm.2020.04.07. Ann Transl Med. 2020. PMID: 32793658 Free PMC article. No abstract available.
-
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines.Mol Pharmacol. 2013 Apr;83(4):882-93. doi: 10.1124/mol.112.084111. Epub 2013 Jan 31. Mol Pharmacol. 2013. PMID: 23371912 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous